
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Preventive Medicine [P. H. G., S. G., L. V. H., A. B.], Robert H. Lurie Comprehensive Cancer Center [P. H. G., L. V. H., R. T. C.], and Department of Obstetrics and Gynecology [R. T. C.], Northwestern University Medical School, Chicago, Illinois 60611
Repeated measurement of ovarian steroids in saliva could provide an advantage in studies estimating long-term sex steroid exposure in premenopausal women, by reducing the measurement error associated with collection of serum or urine samples. We previously reported on characteristics of ultrasensitive RIAs adapted for extraction-free measurement of estradiol (E2) and progesterone (PG) in saliva. The purpose of the present study was to evaluate the consistency of E2 and PG levels in saliva in the same women across menstrual cycles, and to compare this with the variation observed between women. We also evaluated the effect of altering the number of consecutive daily samples considered and the method for locating a particular cycle day in relation to ovulation (day 0). Study participants included 12 healthy women who provided daily saliva samples for two consecutive, ovulatory menstrual cycles. A single midluteal serum sample was collected 78 days after detection of a luteinizing hormone (LH) peak in urine. We plotted individual cycle profiles and computed intraclass correlation coefficients (ICC) for various definitions of peak and cumulative daily hormone level. For peak PG, determined as the maximal running 3-day mean, ICC was 0.68. For cumulative PG, based on 8 consecutive cycle days (+2 to +9), ICCs were 0.720.76 when reverse dating LH peak or rise in salivary PG determined day 0. For E2, ICCs ranged from 0.74 to 0.79 by various dating methods for the 5 preovulatory days (-40), and from 0.85 to 0.92 for the 15 days about the center of the cycle (-6 to +8). With exclusion of just the first 5 days of the cycle, the ICC for E2 was 0.91. For both E2 and PG, selection of 5 or 7 days for the estimation of the midluteal mean level provided separation of within and between subject variance that was comparable with a LH-timed serum sample. These results indicate that daily saliva samples can be combined to clarify the interindividual differences in E2 and PG levels in premenopausal women, and that these interindividual differences may be greater than previously imagined.
This article has been cited by other articles:
![]() |
J. J. Sherman and L. LeResche Does experimental pain response vary across the menstrual cycle? A methodological review Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R245 - R256. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Gann, A. S. Geiger, I. B. Helenowski, E. F. Vonesh, and R. T. Chatterton Estrogen and Progesterone Levels in Nipple Aspirate Fluid of Healthy Premenopausal Women: Relationship to Steroid Precursors and Response Proteins Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 39 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T Chatterton Jr, E. T Mateo, N. Hou, A. W Rademaker, S. Acharya, V C. Jordan, and M. Morrow Characteristics of salivary profiles of oestradiol and progesterone in premenopausal women J. Endocrinol., July 1, 2005; 186(1): 77 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Chatterton Jr., A. S. Geiger, S. A. Khan, I. B. Helenowski, B. D. Jovanovic, and P. H. Gann Variation in Estradiol, Estradiol Precursors, and Estrogen-related Products in Nipple Aspirate Fluid from Normal Premenopausal Women Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 928 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ahmad, T. M. Pollard, and N. Unwin The Optimal Timing of Blood Collection during the Menstrual Cycle for the Assessment of Endogenous Sex Hormones: Can Interindividual Differences in Levels over the Whole Cycle Be Assessed on a Single Day? Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 147 - 151. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |